The comeceutical, pharmaceutical and nutraceutical firm SOHM Inc (OTCMKTS:SHMN) has been in significant focus among investors in recent days and in the past week the stock has managed to clock gains of as much as 7%. In light of such gains, it may be a good time for investors to perhaps consider taking a look at a development from yesterday with regards to SOHM.
Trading Data
On Wednesday, SHMN stock ended flat at $0.0016 with more than 4.95 million shares traded, compared to its average volume of 6.2 million shares. The stock moved within a range of $0.0014 – 0.0016 after opening trading at $0.0016.
SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.
Yesterday, the company announced that it had signed up Dr David Aguilar to serve on the Advisory Board of SOHM in the capacity of an Expert Medical Advisor. It was a major new appointment from the company and one that could help the company in the long run as well.
Dr Aguilar is regarded as a highly experienced leader in the field of CMC activities. In addition to that, the CMC activities he is involved in are concerned with IND filings for allogeneic cell based therapeutics and pre-clinical filings as well. Dr Aguilar stated that he was honoured at having been inducted to the advisory board of the company. At this point, it remains to be seen if the SOHM stock can manage to add to its gains in the coming days.
Key Quote
“I am honored to welcome Dr. Aguilar to our advisory board”, Mr. Baron Night, President and CEO of SOHM Inc. said. “Dr. Aguilar’s expertise and years of experience in novel reagents and regenerative medicine will greatly benefit SOHM’s current and future pipelines.”
Traders Corner
SHMN stock is trading below the 20-Day and 50-Day Moving averages of $0.0018 and $0.0021 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0038.
